The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of tinengotinib in advanced cholangiocarcinoma: Analysis of molecular response and resistance mechanisms.
 
Angela Lamarca
Honoraria - Advanced Accelerator Applications; Advanz Pharma; AstraZeneca; Eisai; Incyte; Ipsen; Jazz Therapeutics; Merck; MSD Oncology; Novartis; Pfizer; QED Therapeutics; Roche; Servier; Taiho Oncology
Consulting or Advisory Role - Albireo Pharma; AstraZeneca/MedImmune; Boehringer Ingelheim; Boston Scientific; EISAI; GENFIT; Ipsen; MSD Oncology; Nutricia; QED Therapeutics; Roche; SERVIER; Taiho Pharmaceutical; TransThera Biosciences
Research Funding - Albireo Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); GENFIT (Inst); Ipsen; Jazz Therapeutics (Inst); Merck (Inst); Novartis (Inst); QED Therapeutics (Inst); Relay Therapeutics (Inst); Roche (Inst); SERVIER (Inst); Taiho Oncology (Inst); TransThera Biosciences (Inst)
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Advanz Pharma; Bayer; Celgene; Delcath Systems; Ipsen; Mylan; Novartis; Pfizer; Roche; Sirtex Medical
 
Milind Javle
Honoraria - AstraZeneca/MedImmune; EMD Serono/Merck; Incyte; Merck; QED Therapeutics; TransThera Biosciences
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; EMD Serono; incyte; Merck; Mundipharma; oncosil; QED Therapeutics
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen
 
Christos Fountzilas
Consulting or Advisory Role - Astellas Pharma (Inst)
Research Funding - Amgen (Inst); Aravive (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bellicum Pharmaceuticals (Inst); Biomea Fusion (Inst); CrystalGenomics (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst); Imugene (Inst); Ipsen (Inst); Legend Biotech USA Inc (Inst); Merck (Inst); Pfizer (Inst); Revolution Medicines (Inst); Sanofi (Inst); Taiho Oncology (Inst); Torl Biotherapeutics (Inst); TransThera Biosciences (Inst); Valar Labs (Inst)
 
Chih-Yi Liao
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boston Scientific; Exelixis; Genentech; Histosonics; Incyte; Ipsen; Lexicon; Lilly; QED Therapeutics; Taiho Pharmaceutical; TransThera Biosciences
Speakers' Bureau - AstraZeneca; Eisai; Exelixis; Incyte
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Exelixis; Incyte; Ipsen
 
Meredith Pelster
Honoraria - Castle Biosciences (I)
Consulting or Advisory Role - Arcus Biosciences (Inst); AstraZeneca (Inst); Curio Science (Inst); CytomX Therapeutics (Inst); Elevation Oncology (Inst); EMD Serono (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Research Funding - 1200 Pharma (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Affini-T Therapeutics (Inst); Agenus (Inst); Arcus Biosciences (Inst); Artios (Inst); Astellas Pharma (Inst); BeiGene (Inst); BioNTech (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Codiak Biosciences (Inst); Compass Therapeutics (Inst); CytomX Therapeutics (Inst); Eisai (Inst); Elevation Oncology (Inst); Elicio Therapeutics (Inst); Exelixis (Inst); Fate Therapeutics (Inst); Fog Pharmaceuticals (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); HiberCell (Inst); Immune-Onc Therapeutics (Inst); IMPAC Medical Systems (Inst); Jazz Pharmaceuticals (Inst); Kura Oncology (Inst); Leap Therapeutics (Inst); Neogene (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Panbela Therapeutics (Inst); Revolution Medicines (Inst); Roche (Inst); Seagen (Inst); SQZ Biotechnology (Inst); Surface Oncology (Inst); Tachyon Therapeutics (Inst); Takeda (Inst); Translational Genomics Research Institute (Inst); TransThera Sciences (Nanjing), Inc. (Inst); ZielBio (Inst)
 
Daneng Li
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Coherus Biosciences; Eisai; Elevar Therapeutics; Exelixis; Genentech; Ipsen; Jazz Pharmaceuticals; Kite, a Gilead company; Merck; Merus; Novartis; Ono Pharmaceutical; Sanofi; Tersera
Research Funding - AstraZeneca (Inst)
 
Dustin Deming
Consulting or Advisory Role - DoMoreDx; Exelixis; Foundation Medicine; Inocras; Pfizer; Regeneron; Seagen; Taiho Oncology
Research Funding - AADi (Inst); Arcus Ventures (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Curegenix (Inst); Genentech (Inst); Ipsen; Lilly (Inst); Merck (Inst); Millennium (Inst); Natera (Inst); Promega (Inst); Revolution Medicines (Inst); Strata Oncology (Inst)
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Autem Medical; Civala; Civala; Delcath Systems; Elevar Therapeutics; Histosonics; Incyte; Ipsen; Jazz Pharmaceuticals; Lynx Group; Revolution Medicines; SERVIER; Tallac Therapeutics; TransThera Biosciences
Research Funding - Actuate Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Elicio Therapeutics (Inst); Esanik (Inst); Exelixis (Inst); FibroGen (Inst); Ipsen (Inst); Jazz Pharmaceuticals (Inst); MedImmune (Inst); Pancreatic Cancer Action Network (Inst); Rafael Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Repare Therapeutics (Inst); SERVIER (Inst); Syros Pharmaceuticals (Inst); TransThera Biosciences (Inst)
Other Relationship - Rafael Pharmaceuticals (Inst)
 
Lionel Aurelien Kankeu Fonkoua
Honoraria - Exelixis (Inst); Incyte (Inst); S2N Health (Inst)
Consulting or Advisory Role - Exelixis (Inst); Incyte (Inst); S2N Health (Inst)
 
Allen Cohn
No Relationships to Disclose
 
Parvez Mantry
No Relationships to Disclose
 
Donald Richards
Consulting or Advisory Role - Grail; Ipsen; Mirati Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Taiho Pharmaceutical
 
Ed Kingsley
No Relationships to Disclose
 
Amit Mahipal
Consulting or Advisory Role - AstraZeneca/MedImmune; Elevar Therapeutics; Guardant Health; Taiho Oncology
Speakers' Bureau - AstraZeneca; Exelixis; Taiho Oncology
Research Funding - Taiho Pharmaceutical
 
Katie Hennessy
Employment - TransThera Biosciences
Travel, Accommodations, Expenses - TransThera Biosciences
 
Hui Wang
No Relationships to Disclose
 
Caixia Sun
Employment - TransThera Sciences (Nanjing), Inc.
 
Jean Fan
Employment - TransThera Biosciences
Leadership - TransThera Biosciences
Stock and Other Ownership Interests - AstraZeneca